Table A2.
Demographics, medical history and medication use according to presence and absence of ExPH at ESE.
| Factor | ExPH at ESE | Mean | SD | p-Value |
|---|---|---|---|---|
| Age | no | 54.58 | 9.94 | 0.391 |
| yes | 51.46 | 13.33 | ||
| BSA | no | 1.90 | 0.20 | 0.932 |
| yes | 1.89 | 0.25 | ||
| Heart rate | no | 69.03 | 6.30 | 0.839 |
| yes | 68.62 | 5.98 | ||
| yes | 126.92 | 9.47 | ||
| DAP | no | 73.79 | 7.18 | 0.308 |
| yes | 76.15 | 6.50 | ||
| ExPH at ESE | ||||
| Factor | no | yes | p-value | |
| Sex | F | 12 | 4 | 0.720 |
| M | 21 | 9 | ||
| Smoke | no | 15 | 4 | 0.570 |
| ex | 1 | 1 | ||
| yes | 17 | 8 | ||
| Functional class FC-WHO | I | 31 | 4 | <0.001 |
| II | 1 | 0 | ||
| III | 1 | 9 | ||
| Chronic liver disease | no | 15 | 9 | 0.146 |
| yes | 18 | 4 | ||
| Kidney disease | no | 29 | 12 | 0.664 |
| yes | 4 | 1 | ||
| Thyroid disease | no | 28 | 12 | 0.499 |
| yes | 5 | 1 | ||
| Arterial hypertension | no | 30 | 12 | 0.880 |
| yes | 3 | 1 | ||
| Dyslipidemia | no | 9 | 7 | 0.088 |
| yes | 24 | 6 | ||
| Diabetes mellitus | no | 28 | 12 | 0.499 |
| yes | 5 | 1 | ||
| Familiarity for CAD | no | 27 | 9 | 0.351 |
| yes | 6 | 4 | ||
| Calcium channel blockers | no | 30 | 11 | 0.937 |
| yes | 3 | 1 | ||
| Hypoglycemic drugs | no | 9 | 7 | 0.088 |
| yes | 24 | 6 | ||
| Beta blockers | no | 33 | 12 | 0.107 |
| yes | 0 | 1 | ||
| ACE inhibitors or sartanics | no | 32 | 13 | 0.526 |
| yes | 1 | 0 | ||
| Thyroid hormones | no | 28 | 12 | 0.499 |
| yes | 5 | 1 | ||
| Lipid lowering drugs | no | 9 | 7 | 0.088 |
| yes | 24 | 6 | ||
Abbreviations: ExPH, isolated exercise pulmonary hypertension; ESE, exercise stress echocardiography; BSA, body surface area; F, female; M, male; CAD, coronary artery disease; ACE, angiotensin converting enzyme.